Connect with us

Brands

Emzor Pharmaceuticals to list N13.73bn bonds on NGX

Published

on

Adebayo Obajemu

Emzor Pharmaceuticals Industry Limited for the first time accessed the domestic debt capital markets to raise 5 years financing in local currency using a corporate bond by issuing a NGN13.73 billion 5-Year 10% Series 1 Senior Unsecured Fixed Rate Bond due 2026 under a NGN50 billion Debt Issuance Programme.

The N13.73 Billion Series 1 Unsecured Bonds was accorded a ‘A-’ credit rating by Global Credit Rating Co. and was undersubscribed by 8.47%, with the intended capital raise valued at NGN15 billion. The bond instrument will be exclusively listed on the NGX Ltd platform.

Emzor Pharmaceutical Industries Limited is a private indigenous pharmaceutical manufacturing group founded in 1984 by Dr. Stella C.Okoli, OON. The company manufactures high-quality pharmaceutical products and medical consumables.

From the modest beginning with four (4) products in 1987, the company now manufactures a wide range of products in the analgesic, anti-malaria, vitamin/haematinics/multivitamin supplement, anti-helmintic, antibiotics and therapeutic categories. The company has in its stable more than 120 different products

Continue Reading
Advertisement
1,113 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *